Related Experiment Video
Updated: May 2, 2026

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
Advanced glycation end products promote heart failure through inducing the immune maturation of dendritic cells
Weiwei Cao1, Jianwen Chen, Yanfang Chen
1Lab of Pharmacology and Toxicology, School of Pharmaceutical Science, Sun Yat-sen University, East of Ring Road No. 132, Guangzhou Higher Education Mega Center, Guangdong, 510006, China.
Abstract:
Advanced glycation end products (AGEs) and dendritic cells (DCs) are believed to play a key role in the development and progression of cardiovascular diseases. However, their role and interactive mechanism remain uncertain. The aim of the present study is to investigate the mechanism of AGE- and DC-mediated heart failure. Time- and dose-dependent western blot and immunohistochemical analysis showed a significant upregulation in the expression of AGEs, receptor for AGEs (RAGE), and OX-62. Further hemodynamic and echocardiogram analysis revealed that AGEs mediate cardiac failure. Treatment with pioglitazone improved heart function by decreasing the expression of AGEs and OX-62 in the rats with myocardial infarction (MI) plus diabetes. AGEs induced the maturation of DCs in both time- and concentration-dependent manner with upregulation in RAGE and dendritic markers. Further, coculture of cardiomyocytes with DCs in the presence of AGEs significantly upregulated hypertrophy-associated genes as determined by real-time PCR. In conclusion, the present study shows clear evidence that AGEs promote heart failure via the maturation of DCs. In addition, inhibition of AGEs by pioglitazone alleviates accumulation of DCs and thus improves heart function.
Related Concept Videos
Pathophysiology of Heart Failure
Diabetic Nephropathy
Heart Failure II: Pathophysiology
Diabetic Neuropathy
Coronary Artery Disease I: Introduction
Type I Diabetes II: Pathophysiology

